Researchers have identified specific proteins that drive the development of cancer stem cells. They report targeting and suppressing galectin1, in addition to radiation therapy, could be an effective treatment for glioblastoma brain cancer.
Cellular reprogramming of glioma cells into neural cells may be a promising treatment for glioblastoma brain cancer.
A combination of approved and novel therapeutics improved survival rates and reduced both tumor volume and growth for those suffering from glioblastoma brain cancer.
Variations in the TSPO neuroinflammation-associated protein's structure correlates with worse survival outcomes for male glioblastoma brain cancer patients than females.
Combining Disulfiram, a medication commonly used to treat chronic alcoholism, with copper ions kills medulloblastoma cancer cells and prevents new ones from growing.
Asthma causes T cells to induce lung inflammation but prevents the growth of brain tumors. Reprogramming T cells in patients with brain cancer to act like T cells in those with asthma may help to curb the growth of tumors.
Inhibition of the OR5B21 olfactory receptor gene significantly decreased the metastasis of breast cancer cells to the brain, lungs, and bones, researchers report.